Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Thrombocythemia, Essential 1Smoldering Multiple Myeloma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Pain 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3Curcumin 3Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cyclosporine 2Busulfan 2Biopsy 2Antilymphocyte Serum 2pyroxamide 1piperine 1liposomal amphotericin B 1isatuximab 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Urination 1Topotecan 1Tissue Banks 1Therapeutics 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sucrose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Monoclonal Gammopathy of Undetermined Significance × piperine × Clear all
NCT04731844 2026-05-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

University of Rochester

Phase 2 Completed
30 enrolled 13 charts
GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡